Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
This grant opportunity focuses on studying incretin mimetic agents and their effects on thyroid, prostate, and other cancer risks, highlighting their favorable efficacy and side effect profiles compared to other similar drugs. The grant aims to attract talented scientists to explore these effects in both cancer and non-cancer diseases. Researchers interested in studying DPP-4 inhibitors or oth…
Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for investigator-initiated studies addressing mechanisms by which incretin mimetics, specifically glucagon-like peptide ( GLP)-1 or dual GLP-1/ glucose?dependent insulinotropic polypepide …
Funding Source
Eligibility
- Foreign eligibility: Non-domestic (non-U.S.) entities (foreign organizations) are eligible to apply. Non-domestic components of U.S. organizations are eligible to apply. Foreign components are allowed.
- Required registrations (must be completed before submission; some steps can tak…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers